Mostrar el registro sencillo del ítem

dc.contributor.author
Iglesias Molli, Andrea Elena  
dc.contributor.author
Panero, Julieta  
dc.contributor.author
Dos Santos, Patricia Carolina  
dc.contributor.author
González, Claudio Daniel  
dc.contributor.author
Vilariño, Jorge  
dc.contributor.author
Sereday, Marta  
dc.contributor.author
Cerrone, Gloria Edith  
dc.contributor.author
Slavutsky, Irma Rosa  
dc.contributor.author
Frechtel, Gustavo Daniel  
dc.date.available
2018-04-17T16:45:10Z  
dc.date.issued
2017-04  
dc.identifier.citation
Iglesias Molli, Andrea Elena; Panero, Julieta; Dos Santos, Patricia Carolina; González, Claudio Daniel; Vilariño, Jorge; et al.; Metabolically healthy obese women have longer telomere length than obese women with metabolic syndrome; Public Library of Science; Plos One; 12; 4; 4-2017; 1-13  
dc.identifier.issn
1932-6203  
dc.identifier.uri
http://hdl.handle.net/11336/42271  
dc.description.abstract
Introduction: Obesity is the principal component in the Metabolic Syndrome (MetS) that determines the progression of metabolic complications. Metabolically healthy obese (MHO) individuals seem to be protected against those complications. Telomere length (TL) as a novel marker of cellular aging had a complex relationship to the MetS. The principal aim of this study was to investigate the TL in MHO, and to study the association between TL and the worsening of the metabolic condition. Material and methods: We have determined the absolute TL (aTL) in 400 women (mean age of 46.76 - 15.47 years; range: 18-86 years), grouped according to the metabolic condition in three groups: metabolically healthy non-obese women (MHNO), MHO and obese women with MetS (MSO); and grouped according to the number of components of MetS. Results: We found that MHO displays significantly higher aTL than MSO (p = 0.033; r = -4.63; 95% CI r = -8.89 / -0.37), but did not differ from MHNO. A decrease in aTL with the progressive increase in the number of MetS components was also observed (p = 0.001; r = -2.06; 95% CI r = -3.13 / -0.99). In this way, our results indicate that aTL is influenced by the presence of MetS, but it is not affected by the presence of obesity. Discussion: We found that shorter aTL is not associated with MHO, but is related to MetS and with the increased number of metabolic abnormalities.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Public Library of Science  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
Metabolic Syndrome (Mets)  
dc.subject
Metabolically Healthy Obese (Mho)  
dc.subject
Metabolically Healthy Non-Obese Women (Mhno)  
dc.subject
Obese Women with Mets (Mso)  
dc.subject
Telomere Length (Tl)  
dc.subject.classification
Medicina Critica y de Emergencia  
dc.subject.classification
Medicina Clínica  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
Metabolically healthy obese women have longer telomere length than obese women with metabolic syndrome  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2018-04-04T14:34:58Z  
dc.identifier.eissn
1932-6203  
dc.journal.volume
12  
dc.journal.number
4  
dc.journal.pagination
1-13  
dc.journal.pais
Estados Unidos  
dc.journal.ciudad
San Francisco  
dc.description.fil
Fil: Iglesias Molli, Andrea Elena. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Inmunología, Genética y Metabolismo. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Inmunología, Genética y Metabolismo; Argentina  
dc.description.fil
Fil: Panero, Julieta. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina  
dc.description.fil
Fil: Dos Santos, Patricia Carolina. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina  
dc.description.fil
Fil: González, Claudio Daniel. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Microbiología, Inmunología y Biotecnología. Cátedra de Microbiología; Argentina  
dc.description.fil
Fil: Vilariño, Jorge. Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia; Argentina  
dc.description.fil
Fil: Sereday, Marta. Hospital Fiorito; Argentina  
dc.description.fil
Fil: Cerrone, Gloria Edith. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Microbiología, Inmunología y Biotecnología. Cátedra de Microbiología; Argentina  
dc.description.fil
Fil: Slavutsky, Irma Rosa. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina  
dc.description.fil
Fil: Frechtel, Gustavo Daniel. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Inmunología, Genética y Metabolismo. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Inmunología, Genética y Metabolismo; Argentina  
dc.journal.title
Plos One  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/https://doi.org/10.1371/journal.pone.0174945  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0174945